Work

Demonstration of Preclinical Efficacy in Pulmonary Fibrosis Models and of Clinical Safety, Tolerability, and Pharmacodynamic Effects of the First-in-Class Angiotensin AT2-Receptor Agonist Compound 21 (C21)

Year: 2018

Type: other

Source: University of Southern Denmark Research Portal (University of Southern Denmark)

Authors: Steckelings, U. Muscha; id_orcid 0000-0002-5430-4275, Lindblad, Lena, Vaiano, P, Graens, Johanna, Dahlöf, Björn, Jansson, Per, Unger, Thomas, Korhonen, Pasi, Wiksten, A., Bruce, Erin, Rathinasabapathy, Anandharajan, Shenoy, Vinayak, Sumners, Colin, Katovich, Michael J, Scheinin, Mika

Institution: University of Southern Denmark

Language: English

Topic: Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4412240745

Cites:

Cited by: 2

Related to: 10